Akso Health Group

Akso Health Group

AHG
Akso Health GroupUS flagNASDAQ
1.55
USD
+0.02
- -
146.83MMarket Cap
Akso Health Group
AHG
(NASDAQ)

Recent

price

1.55

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.29
0.74
1.43
7.15
0.23
0.43
- -
0.3
0.58
0.05
0.05
0.95
Revenue per Share
-0.02
0.22
0.54
4.37
0.34
-4.38
-2.14
-0.85
-0.06
-0.2
-0.47
-1.49
Basic EPS, GAAP
0.15
0.43
0.49
5.82
-0.11
-3.6
0.62
-0.43
-0.14
0.03
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
1.2
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
0.2
0.74
5.15
4.3
-0.09
-2.23
-2.67
-2.38
-1.35
-0.7
3.21
Book Value per Share
- -
0.88
1.47
9.32
7.79
2.96
1.06
0.62
0.39
2.93
0.63
6.16
Tangible Book Value per Share
16
16
16
15
16
16
16
20
23
47
285
16
Basic Weighted Avg Shares
5
12
23
107
4
7
- -
6
13
2
15
16
Sales/Revenue/Turnover
-6.43
34.81
43.25
70.74
-194.55
-237.43
- -
-40.94
-108.23
-357.78
-26.55
-194.97
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
- -
Depreciation Expense
- -
4
9
65
6
-71
-35
-17
-1
-9
-135
-24
Net Income, GAAP
- -
15.08
15.08
14.41
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-7.54
29.75
37.39
61.05
149.72
-1,029.7
- -
-280.85
-10.32
-391.78
-913.38
-156.6
Profit Margin (%)
- -
1
23
139
71
40
16
12
9
138
182
26
Working Capital
- -
- -
- -
- -
20
20
- -
- -
- -
- -
- -
21
LT Debt
- -
14
24
140
127
48
17
12
9
138
199
100
Total Equity
- -
43.64
38.52
69.2
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
221.67
114.62
147.07
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
221.67
114.62
147.14
7.53
- -
- -
- -
- -
- -
- -
-39.69
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'19
Jun'20
Sep'20
ST Debt
- -
2
3
LT Borrowings
20
20
20
LT Finance Leases
- -
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
49
49
49
Market Capitalization
488
349
224

Working Capital

FRC

in mil. unless spec.
Mar'19
Jun'20
Sep'20
Total Current Assets
98
59
38
Cash, Cash Equivalents & STI
57
26
15
Accounts Receivable, Net
- -
1
1
Inventories
- -
- -
- -
Total Current Liabilities
27
11
12
Payables & Accruals
26
10
9
ST Debt
- -
2
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
277.77%
43.87%
Free Cash Flow
384.13%
-106.24%
-24.31%
Net Income, GAAP
-5.48%
345.59%
1,327.01%
Sales/Revenue/Turnover
- -
- -
512.08%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
2
2025
- -
- -
- -
- -
15
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.2
2025
- -
- -
- -
- -
-0.47
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Akso Health Group (Ticker: AHG) is a healthcare-oriented company specializing in the development, manufacturing, and distribution of advanced medical devices, health technology solutions, and related healthcare services. Its core products include medical diagnostic equipment, therapeutic devices, digital health platforms, and related consumables. The company offers these products and services primarily to hospital systems, clinics, and healthcare providers across multiple geographic regions, including North America, Europe, and Asia. Founded in 2008 and headquartered in Shanghai, China, Akso Health Group also operates several subsidiaries focused on specific healthcare segments and technology innovations. In the past 1-2 years, Akso Health Group has undergone strategic business expansions and forged key partnerships to enhance its market presence and innovation capabilities. Notable developments include recent alliances with leading global pharmaceutical and biotechnology firms to integrate their health technology platforms with advanced diagnostics and therapeutic solutions. The company launched several new digital health products aimed at remote patient monitoring and chronic disease management. Additionally, Akso Health Group completed a significant acquisition of a European medical device manufacturer to expand its footprint in the region and broaden its product portfolio. There were no reported name changes or reorganization events in the latest period. Operating within the healthcare technology and medical devices industry, Akso Health Group targets hospitals, private clinics, and health systems seeking innovative diagnostic and treatment technologies. Its product lineup encompasses medical imaging devices, patient monitoring systems, digital health apps, and health data management services. The company leverages a global supply chain and maintains operations primarily in China, the United States, Germany, and select Asian markets. Its corporate strategy focuses on advancing healthcare digitization and personalized medicine through integrated technology solutions, making it a notable player in the global healthtech sector.

Company News

APIChatGPT
  • AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology

  • Akso Health Group (NASDAQ:AHG) Stock Price Down 5.3% – Time to Sell?

  • Treasure Global (NASDAQ:TGL) and Akso Health Group (NASDAQ:AHG) Critical Analysis

  • Head-To-Head Contrast: NextPlat (NASDAQ:NXPL) versus Akso Health Group (NASDAQ:AHG)

  • Financial Contrast: NextPlat (NASDAQ:NXPL) vs. Akso Health Group (NASDAQ:AHG)

  • Akso Health Group (NASDAQ:AHG) Shares Gap Up – Still a Buy?

  • Akso Health Group Announces Launch of Exploratory Global Patient Support Initiative

  • Akso Health Group (NASDAQ:AHG) Shares Gap Up – What’s Next?

  • Akso Health Group Sponsored ADR (NASDAQ:AHG) Short Interest Down 27.4% in December

  • Akso Health Group (NASDAQ:AHG) Trading Down 6% – Here’s Why

  • Akso Health Group (NASDAQ:AHG) Shares Gap Up – What’s Next?

  • Head-To-Head Review: Akso Health Group (NASDAQ:AHG) versus TripAdvisor (NASDAQ:TRIP)

  • Head to Head Review: Prosus (OTCMKTS:PROSY) versus Akso Health Group (NASDAQ:AHG)

  • AHG Utilizes DeepSeek to Advance AI in Healthcare

  • AHG Announces Plan to Acquire Online Clinic

  • Akso Health Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement